Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
21.6M
-
Shares change
-
+142K
-
Total reported value, excl. options
-
$718M
-
Value change
-
+$5.11M
-
Put/Call ratio
-
0.62
-
Number of buys
-
55
-
Number of sells
-
-44
-
Price
-
$33.25
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q4 2017
123 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q4 2017.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.6M shares
of 51.1M outstanding shares and own 42.21% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.28M shares), FMR LLC (2.09M shares), RTW INVESTMENTS, LP (1.56M shares), JPMORGAN CHASE & CO (1.52M shares), Redmile Group, LLC (1.43M shares), PERCEPTIVE ADVISORS LLC (1.42M shares), Vanguard Group Inc (1.22M shares), STATE STREET CORP (1.07M shares), CITADEL ADVISORS LLC (988K shares), and FRANKLIN RESOURCES INC (871K shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.